← all drugs
Cisatracurium Besylate Injection
being discontinued · Analgesia/Addiction · Snapshot: 2026-10-09
- Manufacturers listed
- Hospira, Inc., a Pfizer Company
- Machine-readable
- JSON for this drug
Presentations (3)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02) | Hospira, Inc., a Pfizer Company | unknown | 09/11/2026 |
| Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01) | Hospira, Inc., a Pfizer Company | unknown | 05/06/2026 |
| Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01) | Hospira, Inc., a Pfizer Company | unknown | 05/06/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.